IMMUNOGENIC PEPTIDES FOR USE IN THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES AUTOIMMUNE DISEASES IMMUNE RESPONSES TO ALLOFACTORS ALLERGIC DISEASES TUMORS GRAFT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENE THERAPY OR GENE VACCINATION
The invention describes new peptides containing epitopes recognized by CD4+ natural killer T (NKT) cells for increasing activity for use in infectious diseases autoimmune diseases immune reaction to administration of allofactors allergic diseases therapy of tumors prevention of graft rejection and prevention of immunization against viral proteins used in gene therapy or gene vaccination.